SCHEMBL24940723

SCHEMBL24940723

COc1cc(CC(=O)N(C)CC[C@H]2CCc3ccc(C)nc3N2)nc(C)n1

nearest known ligand 0.30

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ TAF1 P21675 1/20 0.30
▸ CECR2 Q9BXF3 1/20 0.30
▸ BRD9 Q9H8M2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24940864 0.84 HCRTR1 (0.32) —
SCHEMBL24939965 0.83 MC4R (0.33) —
SCHEMBL24940726 0.71 MC4R (0.33) —
SCHEMBL24094652 0.62 MC4R (0.42) —
SCHEMBL25586722 0.62 MC4R (0.40) —
SCHEMBL25586720 0.62 MC4R (0.40) —
SCHEMBL24940770 0.61 NAMPT (0.35) —
SCHEMBL4253493 0.60 PDE10A (0.45) —
SCHEMBL24939971 0.59 HCRTR1 (0.33) —
SCHEMBL8835616 0.56 PDE2A (0.47) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230019853-A1 MELANOCORTIN 4 RECEPTOR ANTAGONISTS AND USES THEREOF PFIZER INC. (US) 2023-01-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230019853-A1 MELANOCORTIN 4 RECEPTOR ANTAGONISTS AND USES THEREOF MC4R, MC3R, MC5R TAF1 2899/4885CECR2 1569/4885BRD9 2601/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback